23 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table Insulin ... SGLT2 inhibitors ... adverse CV events, Improved ... comparison #management #endocrinology
Insulin - Comparison - Peak and Duration

#insulin #pharmacology #duration #peak #diabetes #endocrinology #Comparison
Insulin - Comparison ... and Duration #insulin ... #pharmacology # ... duration #peak #diabetes ... #endocrinology
Insulin Comparison Chart

Insulin Types - Onset (hours) - Peak Glycemic Effect (hours) - Duration (hours)
 •
Insulin Comparison ... Chart Insulin ... • Combination Insulins ... Comparison #Table #pharmacology ... #diabetes #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Sulfonylurea, TZD, DPP-4 inhibitor ... α-glucosidase inhibitor ... #Medications #pharmacology ... comparison #table #endocrinology
The principles of insulin adjustment guidance - Schematic diagram of insulin onset and time action profiles
principles of insulin ... and Duration #Diabetes ... #Insulin #Analogs ... Peaks #Comparison #Pharmacology ... #Endocrinology
Insulin Analogs - Short, Intermediate and Long Acting - Onset, Peak, Duration

#Diabetes #Insulin #Analogs #Onset #Duration
Insulin Analogs ... , Duration #Diabetes ... #Insulin #Analogs ... Peaks #Comparison #Pharmacology ... #Endocrinology
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Hypoglycemics in Diabetes ... Management 1 INSULIN ... Glucophage) 2 INSULIN ... CARB ABSORPTION INHIBITOR ... #Management #pharmacology
SNRls (Serotonin/Norepinephrine Reuptake Inhibitors) - FDA Approved Indications 

Venlafaxine (Effexor) - GAD, MDD, Panic Disorder, SAD
Norepinephrine Reuptake Inhibitors ... Cymbalta) - GAD, MDD, Diabetic ... Serotonin-Norepinephrine Reuptake Inhibitors ... #Indications #Pharmacology ... #Psychiatry #FDA
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... Canagliflozin) being approved ... Ertugliflozin) being approved ... #Pharmacology # ... #Endocrinology
Effects on body weight of various classes of type-2 diabetes medications.
 - Metformin - Weight Loss
classes of type-2 diabetes ... Loss + - SGLT-2 inhibitors ... Loss +++ - DPP-4 inhibitors ... Weight Gain ++ - Insulin ... weightgain #comparison #pharmacology